Managing AsThma AnD Obesity Related Symptoms (MATADORS) Feasibility Study
- Conditions
- Asthma in ChildrenObesityObesity, ChildhoodObesity, Adolescent
- Interventions
- Behavioral: MATADORS ControlBehavioral: MATADORS
- Registration Number
- NCT05742646
- Lead Sponsor
- Medical University of South Carolina
- Brief Summary
The purpose of this 4 week pilot study is to test the use of a mobile application (also commonly referred to as an app) designed to help increase self-management strategies among youth that have asthma and obesity. The data obtained from this study will facilitate refinement of the app and interventional approaches for a future larger scale study to increase youth self-management of their clinical conditions, symptom management, and health maintenance as they transition to adulthood.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
-
Youth-Caregiver Dyad Inclusion Criteria:
- Male and female youth aged 10 - 17 years
- Adult primary caregiver (18 years and older)
- English speaking
- Youth diagnosis of asthma
- Prescribed inhaler treatment for asthma
- Youth Body Mass Index at or above the 85th percentile for age and sex based on the Centers for Disease Control (CDC) growth charts
- Must own a smartphone (iOS) with working Wi-Fi access and/or cellular data plan
- Prescribed inhaler treatment for asthma
- Diagnosis of cognitive impairment
- Inability or unwillingness of youth participant to assent and/or primary caregiver/legal guardian/representative to give informed consent
- Inability or unwillingness to participate in the audio recording interview session or complete study procedures
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description MATADORS app basic information MATADORS Control - MATADORS app to include basic information and expanded educational features MATADORS -
- Primary Outcome Measures
Name Time Method Number of participants completing 4-week study period 4-week study period Participant retention and feasibility in completing the 4-week study
- Secondary Outcome Measures
Name Time Method End of study dyadic interviews 8 weeks Number of completed end of study dyadic interviews
Change in Self-Efficacy 8 weeks Change in Self-Efficacy (measured by Change in Self-Efficacy for Managing Chronic Disease-6 item scale). This is a 6-item instrument reported on an analog scale that highlights one's confidence in managing their chronic disease. Each item ranges from 1 (not confident at all) to 10 (extremely confident). The higher the total score indicates the higher the level of self-efficacy.
Change in Asthma Control 8 weeks Change in asthma control (measured by Asthma Control Test). Scores range from 5 (poor control of asthma) to 25 (complete control of asthma), with higher scores reflecting greater asthma control. An ACT score \>19 indicates well-controlled asthma.
Daytime sleepiness Daily for 28 days Self-report of daytime sleepiness
Loss to follow-up 8 weeks Number of participants lost to follow-up
Sleep patterns Daily for 28 days Number of hours of sleep per day as reported through activity tracker
Inability to concentrate Daily for 28 days Self-report on inability to concentrate
Short Assessment of Health Literacy-English Baseline 18-item instrument to assess the ability to read and understand common medical terms. A score between 0 and 14 suggests the examinee has low health literacy.
Study withdrawals 8 weeks Number of participants who self withdrew from the study
Change in Fatigue 8 weeks Change in Fatigue (measured by PROMIS Pediatric Fatigue)-Self-report of fatigue symptoms ranging from tiredness to overwhelming exhaustion. Low score indicates a low level of fatigue and a high score may represent extreme or debilitating levels of exhaustion
Physical Activity Patterns Daily for 28 days Number of minutes active per day
Symptom reporting Daily for 28 days Number of days reporting symptoms of fatigue, pain, anxiety, depression
Activity tracker-step count Daily for 28 days Number of steps taken per day based reported through activity tracker
Asthma Belief Survey Baseline, week 4, and week 8 The instrument is a 15-item tool that uses a 5-point self-report scale to measure asthma self-efficacy in relation to daily asthma maintenance and an asthma crisis. A rating of 1 = little confidence whereas a rating of 5 = a high confidence level. Responses are averaged across items to indicate an overall score ranging between 1 (low confidence) to 5 (high confidence)
Medication adherence Daily for 28 days Self-report of rescue and/or controller medication usage
Missed school/work/activity Baseline, week 4, and week 8 Self-report of the number of days where the participant missed school, work, or activities
Trial Locations
- Locations (1)
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States